Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 252
7
Diseases
1,744
Unique genes
0.088
Avg. similarity score
Eczema
Most-connected disease (4 links)
Disease
Searched: neurodevelopmental disorder with spasticity, seizures, and brain abnormalities
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
neurodevelopmental disorder with spasticity, seizures, and brain abnormalities
Eczema
Asthma
Obstructive pulmonary disease
Respiratory system disease
Inflammatory skin disease
Intellectual developmental disorder neuropsychiatric
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Eczema | 4 | 4 | 365 |
| Asthma | 3 | 3 | 1,068 |
| Obstructive pulmonary disease | 3 | 3 | 559 |
| Respiratory system disease | 3 | 3 | 241 |
| Inflammatory skin disease | 2 | 2 | 76 |
| Intellectual developmental disorder neuropsychiatric | 2 | 2 | 1 |
| neurodevelopmental disorder with spasticity, seizures, and brain abnormalities | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| EMSY | 5 / 7 | Asthma, Eczema, Inflammatory skin disease, Obstructive pulmonary disease and 1 more |
| ADAM19 | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Obstructive pulmonary disease |
| BACH2 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| CSMD1 | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Obstructive pulmonary disease |
| D2HGDH | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| FADS1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| FADS2 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| GLB1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| HLA-DQA1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| IL18R1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| IL1RL1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| IL2RA | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| ITGB8 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| OTULINL | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| PLXNC1 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| PRR5L | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Respiratory system disease |
| RERE | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| RPS26 | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Obstructive pulmonary disease |
| RUNX3 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| SMAD3 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| SOCS3 | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Respiratory system disease |
| TNFAIP3 | 4 / 7 | Asthma, Eczema, Inflammatory skin disease, Respiratory system disease |
| TSLP | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| UBAC2 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| ZBTB38 | 4 / 7 | Asthma, Eczema, Obstructive pulmonary disease, Respiratory system disease |
| ACO1 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| ADAMTSL3 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| AHI1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| AP5B1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| BLTP1 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| CAPSL | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CARD11 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CCR7 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CD247 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CEBPA | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CLEC16A | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| CRCT1 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| CXCR5 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| EEFSEC | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| ERBB3 | 3 / 7 | Asthma, Eczema, Obstructive pulmonary disease |
| ETS1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| FLG | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| GATA3 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| GRM4 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| GSDMB | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| HDAC7 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| HLA-B | 3 / 7 | Asthma, Eczema, Obstructive pulmonary disease |
| HLA-DQB1 | 3 / 7 | Asthma, Eczema, Obstructive pulmonary disease |
| HLA-DRB1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| HLA-DRB5 | 3 / 7 | Asthma, Eczema, Obstructive pulmonary disease |
| HTR4 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| IKZF1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| IL2 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| IL33 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| IL4R | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| IL6R | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| IL7R | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| INPP5D | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| IRF1 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| ITK | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| ITPKA | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| KPNA3 | 3 / 7 | Eczema, Inflammatory skin disease, Obstructive pulmonary disease |
| LCE3E | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| LCE5A | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| LMAN2 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| LRRC43 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| MAP2K4 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| MYRF | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| NCF4 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| NDFIP1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| NFKBIA | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| NOS2 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| NPNT | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| OVOL1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| POLI | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| PSMA6 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| RAD50 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| RAD51B | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| RAF1 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| RAP1GAP2 | 3 / 7 | Asthma, Eczema, Inflammatory skin disease |
| RIN3 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| RORA | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| RORC | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| RTEL1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| RYBP | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SCAF8 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SEPTIN8 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SIK2 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SLC25A46 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SLC45A1 | 3 / 7 | Eczema, Inflammatory skin disease, Intellectual developmental disorder neuropsychiatric |
| SLC7A10 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SLC9A2 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SLC9A4 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SMARCE1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SPATA32 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SPSB1 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| SRGAP2 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| STAT6 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
| TBL1XR1 | 3 / 7 | Asthma, Obstructive pulmonary disease, Respiratory system disease |
| TBX21 | 3 / 7 | Asthma, Eczema, Respiratory system disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Inflammatory bowel disease | KEGG | 50 / 66 | 5.2× | 5.37e-29 | 1.33e-25 ✓ sig. |
| Th17 cell differentiation | KEGG | 53 / 109 | 3.3× | 2.14e-17 | 1.07e-14 ✓ sig. |
| Allograft rejection | KEGG | 29 / 39 | 5.1× | 5.86e-17 | 2.67e-14 ✓ sig. |
| Type I diabetes mellitus | KEGG | 30 / 44 | 4.7× | 8.35e-16 | 3.12e-13 ✓ sig. |
| Asthma | KEGG | 25 / 32 | 5.4× | 1.15e-15 | 4.21e-13 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 46 / 108 | 2.9× | 1.22e-12 | 2.60e-10 ✓ sig. |
| Graft-versus-host disease | KEGG | 27 / 45 | 4.1× | 2.36e-12 | 4.76e-10 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 28 / 50 | 3.9× | 9.63e-12 | 1.77e-9 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 86 / 298 | 2.0× | 8.23e-11 | 1.22e-8 ✓ sig. |
| Th1 and Th2 cell differentiation | KEGG | 39 / 93 | 2.9× | 1.11e-10 | 1.62e-8 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 28 / 54 | 3.6× | 1.13e-10 | 1.64e-8 ✓ sig. |
| Rheumatoid arthritis | KEGG | 39 / 95 | 2.8× | 2.40e-10 | 3.22e-8 ✓ sig. |
| Leishmaniasis | KEGG | 34 / 78 | 3.0× | 4.99e-10 | 6.29e-8 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 66 / 224 | 2.0× | 5.28e-9 | 5.25e-7 ✓ sig. |
| Interleukin-10 signaling | Reactome | 23 / 47 | 3.4× | 2.19e-8 | 1.84e-6 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| immune response | GO:0006955 | 119 / 543 | 2.3× | 3.47e-19 | 4.68e-16 ✓ sig. |
| inflammatory response | GO:0006954 | 104 / 467 | 2.4× | 2.04e-17 | 2.14e-14 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 191 / 1,208 | 1.7× | 8.60e-14 | 4.76e-11 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 133 / 778 | 1.8× | 2.85e-12 | 1.20e-9 ✓ sig. |
| cytokine-mediated signaling pathway | GO:0019221 | 43 / 145 | 3.2× | 3.24e-12 | 1.36e-9 ✓ sig. |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | GO:0002504 | 13 / 15 | 9.3× | 3.43e-12 | 1.43e-9 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 29 / 77 | 4.0× | 1.67e-11 | 5.91e-9 ✓ sig. |
| peptide antigen assembly with MHC class II protein complex | GO:0002503 | 13 / 16 | 8.7× | 1.67e-11 | 5.91e-9 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 37 / 122 | 3.2× | 5.05e-11 | 1.58e-8 ✓ sig. |
| cell surface receptor signaling pathway via JAK-STAT | GO:0007259 | 26 / 67 | 4.2× | 8.48e-11 | 2.52e-8 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 21 / 45 | 5.0× | 8.70e-11 | 2.58e-8 ✓ sig. |
| positive regulation of immune response | GO:0050778 | 19 / 40 | 5.1× | 4.71e-10 | 1.16e-7 ✓ sig. |
| keratinization | GO:0031424 | 26 / 73 | 3.8× | 7.73e-10 | 1.79e-7 ✓ sig. |
| positive regulation of angiogenesis | GO:0045766 | 41 / 159 | 2.8× | 1.19e-9 | 2.64e-7 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 52 / 232 | 2.4× | 1.77e-9 | 3.74e-7 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Asthma | Respiratory system disease | 0.153 | 174 | 1.46e-149 | 2.64e-147 ✓ sig. |
| Eczema | Inflammatory skin disease | 0.208 | 76 | 8.22e-128 | 1.26e-125 ✓ sig. |
| Asthma | Eczema | 0.130 | 165 | 6.56e-95 | 6.53e-93 ✓ sig. |
| Eczema | Respiratory system disease | 0.137 | 73 | 4.23e-61 | 2.63e-59 ✓ sig. |
| Asthma | Obstructive pulmonary disease | 0.083 | 125 | 4.22e-33 | 1.44e-31 ✓ sig. |
| Obstructive pulmonary disease | Respiratory system disease | 0.068 | 51 | 4.47e-25 | 1.10e-23 ✓ sig. |
| Inflammatory skin disease | Intellectual developmental disorder neuropsychiatric | 0.013 | 1 | 4.94e-3 | 6.05e-3 ✓ sig. |
| Eczema | Intellectual developmental disorder neuropsychiatric | 0.003 | 1 | 2.37e-2 | 2.55e-2 ✓ sig. |
| neurodevelopmental disorder with spasticity, seizures, and brain abnormalities | Obstructive pulmonary disease | 0.002 | 1 | 3.63e-2 | 3.83e-2 ✓ sig. |